Bioharvest Sciences Inc
Change company Symbol lookup
Select an option...
CNVCF Bioharvest Sciences Inc
RYN Rayonier Inc
AGM-E Federal Agricultural Mortgage Corp
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
TWTR Twitter Inc
CCL Carnival Corp
ARKW ARK Next Generation Internet ETF
Go


Based in Canada
Company profile

BioHarvest Sciences Inc. is a Canada-based company, which is in the nutraceutical and cannabis markets via its nutraceutical superfruits and cannabis verticals. The Company operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The Company is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The Company is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).

Closing Price
$0.2798
Day's Change
0.0098 (3.63%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.295
Day's Low
0.2657
Volume
(Heavy Day)
Volume:
85,779

10-day average volume:
72,003
85,779

Company Profile

BioHarvest Sciences Inc. is a Canada-based company, which is in the nutraceutical and cannabis markets via its nutraceutical superfruits and cannabis verticals. The Company operates through two segments: Superfruits and Cannabis. The Superfruits segment is engaged in the development, design, manufacture and marketing of VINIA for the retail market. The Cannabis segment is focused on the development, design, manufacture and marketing of medical cannabis. Its nutraceutical superfruits product, VINIA, is made of red grape (Vitis vinifera) cells grown in the Company's bioreactor facility. The Company is also engaged in research and development of its BioFarming technology for use in the cannabis industry. This plant-based technology produces cannabis cells. The Company is engaged in the sales of VINIA in the Israeli and United States markets. Its subsidiaries include BioHarvest Inc., Dolarin Ltd. (Dolarin) and Superfood Nutraceuticals Inc. (Superfood).

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
48.19x
Price/Book (MRQ)
90.97x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

CNVCF is in a share class of common stock
Float
276.0M
Shares Outstanding
454.5M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

  • 1140-625 Howe Street
  • Vancouver, BC V6C 2T6
  • Canada
  • Phone: 6046221186
  • Fax: 6046221186

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.